The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size
- PMID: 20444918
- PMCID: PMC2928903
- DOI: 10.1210/jc.2009-2718
The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size
Abstract
Context: The high incidence of insulin resistance, type 2 diabetes, and metabolic syndrome in Western societies and their impact on quality of life emphasize the importance of identifying underlying susceptibility loci for metabolic diseases. The polycystic ovary syndrome (PCOS) susceptibility locus D19S884 allele 8 (A8) is associated with measures of insulin resistance, beta-cell dysfunction, and other metabolic phenotypes in PCOS families. We now investigate the role of D19S884 A8 in pregnancy.
Objective: Using the multiethnic Hyperglycemia and Adverse Pregnancy Outcome cohort, we assessed the associations of D19S884 A8 with measures of maternal glycemia and fetal size.
Design: We tested for association of maternal D19S884 A8 with maternal outcomes (fasting, 1-h, and 2-h plasma glucose, and fasting and 1-h C-peptide from an oral glucose tolerance test) and fetal and maternal D19S884 A8 with fetal outcomes (birth weight, length, head circumference, sum of skin folds, fat mass, cord C-peptide, and 2-h neonatal plasma glucose).
Subjects: We analyzed 4424 Caucasian mothers and 3347 offspring of northern European ancestry, 1957 Thai mothers and 2089 offspring from Bangkok, 1208 Afro-Caribbean mothers and 1209 offspring from Barbados, and 774 Hispanic mothers and 762 offspring from Bellflower, California.
Results: After adjusting for confounding variables and multiple testing, neither maternal nor fetal D19S884 A8 showed significant evidence for association with any of the outcomes tested.
Conclusions: The PCOS susceptibility locus, D19S884 A8, is not a major factor contributing to glycemia during pregnancy or fetal size in a general obstetric population.
Figures

Similar articles
-
Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis.Reprod Biomed Online. 2013 Feb;26(2):168-74. doi: 10.1016/j.rbmo.2012.10.014. Epub 2012 Oct 23. Reprod Biomed Online. 2013. PMID: 23265956
-
Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.J Clin Endocrinol Metab. 2007 Nov;92(11):4191-8. doi: 10.1210/jc.2007-0761. Epub 2007 Sep 4. J Clin Endocrinol Metab. 2007. PMID: 17785364
-
Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.J Clin Endocrinol Metab. 2014 Aug;99(8):2961-6. doi: 10.1210/jc.2013-4338. Epub 2014 May 30. J Clin Endocrinol Metab. 2014. PMID: 24878041 Free PMC article.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
The role of TGF-β in polycystic ovary syndrome.Reprod Sci. 2014 Jan;21(1):20-31. doi: 10.1177/1933719113485294. Epub 2013 Apr 12. Reprod Sci. 2014. PMID: 23585338 Free PMC article. Review.
Cited by
-
Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.J Androl. 2012 Mar-Apr;33(2):210-5. doi: 10.2164/jandrol.111.013391. Epub 2011 May 19. J Androl. 2012. PMID: 21597087 Free PMC article.
-
Genetics of the polycystic ovary syndrome.Mol Cell Endocrinol. 2013 Jul 5;373(1-2):29-38. doi: 10.1016/j.mce.2012.10.009. Epub 2012 Oct 16. Mol Cell Endocrinol. 2013. PMID: 23079471 Free PMC article. Review.
-
Associations between testosterone, estradiol, and androgen receptor genotype with amygdala subregions in adolescents.Psychoneuroendocrinology. 2022 Mar;137:105604. doi: 10.1016/j.psyneuen.2021.105604. Epub 2021 Nov 24. Psychoneuroendocrinology. 2022. PMID: 34971856 Free PMC article.
-
Obstetric complications in women with IVF conceived pregnancies and polycystic ovarian syndrome.J Hum Reprod Sci. 2014 Jan;7(1):13-8. doi: 10.4103/0974-1208.130802. J Hum Reprod Sci. 2014. PMID: 24829525 Free PMC article. Review.
References
-
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749 - PubMed
-
- Sam S, Dunaif A 2003 Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14:365–370 - PubMed
-
- Legro RS, Castracane VD, Kauffman RP 2004 Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 59:141–154 - PubMed
-
- Dunaif A, Finegood DT 1996 β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942–947 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases